Company Profile

VRM Labs inc (AKA: VRMLABS)
Profile last edited on: 5/19/2023      CAGE: 6Z9Y7      UEI: NBSKEUJBKBL7

Business Identifier: Natural antioxidants
Year Founded
2013
First Award
2016
Latest Award
2022
Program Status
Active
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

102 Ash Court
Easley, SC 29642
   (515) 975-3557
   info@vrmlab.com
   www.vrmlab.com
Location: Single
Congr. District: 03
County: Pickens

Public Profile

VRM Labs owns a novel technology for manufacturing cost effective natural food preservatives for applications in pet food and animal feed industries.· Prot-X™ is a potent natural antioxidant extracted from animal or avian erythrocytes. It is as efficient as current synthetic antioxidants and provides considerable cost savings compared to current natural antioxidants. VRM Labs has validated the efficacy of Prot-X™ in a number of food models including beef, turkey and chicken meat, pet food, as well as in a 100% chicken fat and cod oil models. The firm has received strategic support while in academia from the rendering industry to fund development of Prot-X™ - with those players interested in seeing this technology commercialized. With pet food buyers increasigly interested in products with synthetic components, interest in new natural antioxidants is currently especially high in rendering and pet food industries. However, natural antioxidants are 5-20 times more expensive than synthetic antioxidants, and are not as efficient. · Thus, inexpensive and capable natural antioxidants are of great demand by the industry. · Regulatory agencies also have concerns about some synthetic antioxidants. PROT-X™ – differentiators: VRM's product can be marketed as natural and be considerably less expensive but more efficient than competitors. ·

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
1-4
Revenue Range
Less than .5M
VC funded?
No
Public/Private
Privately Held
Stock Info
----
IP Holdings
N/A

Awards Distribution by Agency

Most Recent SBIR Projects

Year Phase Agency Total Amount
2022 1 NIH $311,321
Project Title: Protective film-forming disinfectant based on chitosan/water/ethanol tertiary solutions
2017 2 USDA $700,000
Project Title: Natural biodegradable flocculants derived from hemoglobin
2016 1 USDA $100,000
Project Title: Novel Natural Antioxidants Extracted from Animal Red Blood Cells

Key People / Management

  Alexey Vertegel -- CEO

  David Meisinger -- COO

  Vladimir Reukov -- CTO

Company News

There are no news available.